{"schema_version":"secwatch.filing_event.v1","accession":"0001524472-24-000003","form_type":"8-K","ticker":"XYL","cik":"0001524472","company_name":"Xylem Inc.","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.487183+00:00","generated_at":"2026-06-06T08:04:36.441741+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Xylem Q4 revenue $2.1B, +41%; FY23 adj. EPS $3.78, +20%; initiates FY24 guidance $4.00-4.20, dividend +9%","bullets":["Q4 orders $2.0B (+42% reported, +10% organic); revenue $2.1B (+41% reported, +9% organic).","Q4 GAAP EPS $1.10 (+34%); adjusted EPS $0.99 (-1%), exceeding guidance.","Full-year 2023 revenue $7.4B (+33% reported, +12% organic); adjusted EPS $3.78 (+20%).","FY2024 guidance: revenue $8.4-8.5B (+14-15% reported, +3-5% organic); adj. EPS $4.00-4.20.","Dividend raised 9% to $0.36/share, payable March 20, 2024; Evoqua integration ahead of schedule."],"urls":{"canonical":"https://secwatch.observer/filing/0001524472-24-000003","json":"https://secwatch.observer/filing/0001524472-24-000003.json","markdown":"https://secwatch.observer/filing/0001524472-24-000003.md","text":"https://secwatch.observer/filing/0001524472-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1524472/000152447224000003/0001524472-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1524472/000152447224000003/xyl-20240206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:04:36.441741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"839655dfd1dcb449e53b8b20dbf34dfcc2ac233f","claim":"Xylem Inc. reported the fiscal year ended December 31, 2023 results: revenue $7.4 billion, EPS $2.79 per share. Guidance initiated.","evidence_excerpt":"Full-Year Highlights • Revenue of $7.4 billion, up 33% on a reported basis and 12% organically • Earnings per share of $2.79, up 42%; $3.78 on an adjusted basis, up 20% • Initiating 2024 full-year revenue guidance of $8.4 to $8.5 billion, up 3% to 5% organically, and adjusted earnings per share range of $4.00 to $4.20","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1524472/000152447224000003/0001524472-24-000003-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$7.4 billion"},{"label":"EPS","value":"$2.79 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"9b8a9a0dfcf524ea88ed3b473f0bb7a44fea072b","claim":"Xylem Inc. reported the quarter ended December 31, 2023 results: revenue $2.1 billion, net income $266 million, EPS $1.10 per share.","evidence_excerpt":"Fourth-Quarter Highlights • Orders of $2.0 billion, up 42% on a reported basis and 10% organically • Revenue of $2.1 billion, up 41% on a reported basis and 9% organically • Earnings per share of $1.10, up 34%; $0.99 on an adjusted basis, down 1%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1524472/000152447224000003/0001524472-24-000003-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Revenue","value":"$2.1 billion"},{"label":"Net income","value":"$266 million"},{"label":"EPS","value":"$1.10 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}